FDA: Database Research Contracts Will Boost Drug-Safety Efforts

Drug Industry Daily
KEYWORDS FDA / risk / Technology
A A

The FDA has signed five-year cooperative research contracts with four organizations through which the agency will continue to conduct postmarketing research via several massive patient databases.

To View This Article:

Login

Subscribe To Drug Industry Daily